nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—type 2 diabetes mellitus	0.244	1	CbGaD
Esomeprazole—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.049	0.108	CbGbCtD
Esomeprazole—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0417	0.0918	CbGbCtD
Esomeprazole—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0417	0.0918	CbGbCtD
Esomeprazole—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0385	0.0847	CbGbCtD
Esomeprazole—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0372	0.0818	CbGbCtD
Esomeprazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0313	0.0689	CbGbCtD
Esomeprazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0279	0.0614	CbGbCtD
Esomeprazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0255	0.0561	CbGbCtD
Esomeprazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0223	0.0491	CbGbCtD
Esomeprazole—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0213	0.047	CbGbCtD
Esomeprazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0202	0.0444	CbGbCtD
Esomeprazole—CYP2C19—Losartan—type 2 diabetes mellitus	0.0195	0.043	CbGbCtD
Esomeprazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0153	0.0336	CbGbCtD
Esomeprazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0146	0.0322	CbGbCtD
Esomeprazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0146	0.0322	CbGbCtD
Esomeprazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0139	0.0305	CbGbCtD
Esomeprazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0103	0.0227	CbGbCtD
Esomeprazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00944	0.0208	CbGbCtD
Esomeprazole—Omeprazole—CYP11A1—type 2 diabetes mellitus	0.00116	0.273	CrCbGaD
Esomeprazole—Pantoprazole—CYP1A2—type 2 diabetes mellitus	0.000522	0.123	CrCbGaD
Esomeprazole—Rabeprazole—CYP1A2—type 2 diabetes mellitus	0.000522	0.123	CrCbGaD
Esomeprazole—Omeprazole—CYP1A2—type 2 diabetes mellitus	0.000426	0.1	CrCbGaD
Esomeprazole—Lansoprazole—CYP1A2—type 2 diabetes mellitus	0.000389	0.0916	CrCbGaD
Esomeprazole—Rabeprazole—CYP3A4—type 2 diabetes mellitus	0.000346	0.0813	CrCbGaD
Esomeprazole—Pantoprazole—CYP3A4—type 2 diabetes mellitus	0.000346	0.0813	CrCbGaD
Esomeprazole—Omeprazole—CYP3A4—type 2 diabetes mellitus	0.000282	0.0663	CrCbGaD
Esomeprazole—Lansoprazole—CYP3A4—type 2 diabetes mellitus	0.000258	0.0606	CrCbGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.00012	0.0021	CbGpPWpGaD
Esomeprazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000119	0.0021	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000118	0.00208	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000117	0.00207	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000117	0.00207	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000116	0.00204	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000111	0.00196	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.00011	0.00193	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000104	0.00184	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	0.000104	0.00183	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000101	0.00177	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000101	0.00177	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	9.94e-05	0.00175	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.91e-05	0.00174	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	9.69e-05	0.00171	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.3e-05	0.00164	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	9.22e-05	0.00162	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	9.12e-05	0.0016	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	9.03e-05	0.00159	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	8.91e-05	0.00157	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.26e-05	0.00145	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	8.23e-05	0.00145	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	7.92e-05	0.00139	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	7.72e-05	0.00136	CbGpPWpGaD
Esomeprazole—Insomnia—Valsartan—type 2 diabetes mellitus	7.57e-05	0.000314	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.53e-05	0.000313	CcSEcCtD
Esomeprazole—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.52e-05	0.000312	CcSEcCtD
Esomeprazole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.51e-05	0.000311	CcSEcCtD
Esomeprazole—Myalgia—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000311	CcSEcCtD
Esomeprazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000311	CcSEcCtD
Esomeprazole—Chest pain—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000311	CcSEcCtD
Esomeprazole—Shock—Metformin—type 2 diabetes mellitus	7.5e-05	0.000311	CcSEcCtD
Esomeprazole—Insomnia—Orlistat—type 2 diabetes mellitus	7.48e-05	0.00031	CcSEcCtD
Esomeprazole—Malaise—Losartan—type 2 diabetes mellitus	7.48e-05	0.00031	CcSEcCtD
Esomeprazole—Anxiety—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.00031	CcSEcCtD
Esomeprazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.47e-05	0.00031	CcSEcCtD
Esomeprazole—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.47e-05	0.00031	CcSEcCtD
Esomeprazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.46e-05	0.00031	CcSEcCtD
Esomeprazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.46e-05	0.00031	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	7.46e-05	0.00131	CbGpPWpGaD
Esomeprazole—Vertigo—Losartan—type 2 diabetes mellitus	7.45e-05	0.000309	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000309	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000309	CcSEcCtD
Esomeprazole—Somnolence—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000309	CcSEcCtD
Esomeprazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.43e-05	0.000308	CcSEcCtD
Esomeprazole—Leukopenia—Losartan—type 2 diabetes mellitus	7.42e-05	0.000308	CcSEcCtD
Esomeprazole—Discomfort—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000307	CcSEcCtD
Esomeprazole—Skin disorder—Metformin—type 2 diabetes mellitus	7.4e-05	0.000307	CcSEcCtD
Esomeprazole—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	7.4e-05	0.0013	CbGpPWpGaD
Esomeprazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000306	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	7.37e-05	0.0013	CbGpPWpGaD
Esomeprazole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.37e-05	0.000306	CcSEcCtD
Esomeprazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.37e-05	0.000306	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.36e-05	0.0013	CbGpPWpGaD
Esomeprazole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000305	CcSEcCtD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	7.36e-05	0.00129	CbGpPWpGaD
Esomeprazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.34e-05	0.000304	CcSEcCtD
Esomeprazole—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000304	CcSEcCtD
Esomeprazole—Palpitations—Losartan—type 2 diabetes mellitus	7.33e-05	0.000304	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	7.32e-05	0.00129	CbGpPWpGaD
Esomeprazole—Nausea—Glimepiride—type 2 diabetes mellitus	7.31e-05	0.000303	CcSEcCtD
Esomeprazole—Nausea—Sitagliptin—type 2 diabetes mellitus	7.28e-05	0.000302	CcSEcCtD
Esomeprazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.28e-05	0.000302	CcSEcCtD
Esomeprazole—Asthenia—Glyburide—type 2 diabetes mellitus	7.28e-05	0.000302	CcSEcCtD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	7.28e-05	0.00128	CbGpPWpGaD
Esomeprazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.28e-05	0.000302	CcSEcCtD
Esomeprazole—Anorexia—Metformin—type 2 diabetes mellitus	7.26e-05	0.000301	CcSEcCtD
Esomeprazole—Cough—Losartan—type 2 diabetes mellitus	7.24e-05	0.0003	CcSEcCtD
Esomeprazole—Urticaria—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.0003	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.23e-05	0.0003	CcSEcCtD
Esomeprazole—Alopecia—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000299	CcSEcCtD
Esomeprazole—Fatigue—Valsartan—type 2 diabetes mellitus	7.22e-05	0.000299	CcSEcCtD
Esomeprazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.000299	CcSEcCtD
Esomeprazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.000299	CcSEcCtD
Esomeprazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000298	CcSEcCtD
Esomeprazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000298	CcSEcCtD
Esomeprazole—Pruritus—Glyburide—type 2 diabetes mellitus	7.18e-05	0.000298	CcSEcCtD
Esomeprazole—Mental disorder—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000297	CcSEcCtD
Esomeprazole—Constipation—Valsartan—type 2 diabetes mellitus	7.16e-05	0.000297	CcSEcCtD
Esomeprazole—Infection—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000296	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.14e-05	0.000296	CcSEcCtD
Esomeprazole—Fatigue—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000296	CcSEcCtD
Esomeprazole—Malnutrition—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000295	CcSEcCtD
Esomeprazole—Shock—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000294	CcSEcCtD
Esomeprazole—Pain—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000293	CcSEcCtD
Esomeprazole—Myalgia—Losartan—type 2 diabetes mellitus	7.06e-05	0.000293	CcSEcCtD
Esomeprazole—Chest pain—Losartan—type 2 diabetes mellitus	7.06e-05	0.000293	CcSEcCtD
Esomeprazole—Arthralgia—Losartan—type 2 diabetes mellitus	7.06e-05	0.000293	CcSEcCtD
Esomeprazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.06e-05	0.000293	CcSEcCtD
Esomeprazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.000293	CcSEcCtD
Esomeprazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.04e-05	0.000292	CcSEcCtD
Esomeprazole—Anxiety—Losartan—type 2 diabetes mellitus	7.04e-05	0.000292	CcSEcCtD
Esomeprazole—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000291	CcSEcCtD
Esomeprazole—Rash—Bromocriptine—type 2 diabetes mellitus	7e-05	0.00029	CcSEcCtD
Esomeprazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.99e-05	0.00029	CcSEcCtD
Esomeprazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.99e-05	0.00029	CcSEcCtD
Esomeprazole—Tension—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000289	CcSEcCtD
Esomeprazole—Discomfort—Losartan—type 2 diabetes mellitus	6.98e-05	0.000289	CcSEcCtD
Esomeprazole—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000289	CcSEcCtD
Esomeprazole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000288	CcSEcCtD
Esomeprazole—Headache—Bromocriptine—type 2 diabetes mellitus	6.95e-05	0.000288	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.94e-05	0.000288	CcSEcCtD
Esomeprazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000288	CcSEcCtD
Esomeprazole—Nervousness—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000287	CcSEcCtD
Esomeprazole—Dry mouth—Losartan—type 2 diabetes mellitus	6.91e-05	0.000286	CcSEcCtD
Esomeprazole—Anorexia—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000284	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.84e-05	0.000284	CcSEcCtD
Esomeprazole—Paraesthesia—Metformin—type 2 diabetes mellitus	6.84e-05	0.000284	CcSEcCtD
Esomeprazole—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000284	CcSEcCtD
Esomeprazole—Confusional state—Losartan—type 2 diabetes mellitus	6.82e-05	0.000283	CcSEcCtD
Esomeprazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000283	CcSEcCtD
Esomeprazole—Dyspnoea—Metformin—type 2 diabetes mellitus	6.79e-05	0.000282	CcSEcCtD
Esomeprazole—Somnolence—Metformin—type 2 diabetes mellitus	6.78e-05	0.000281	CcSEcCtD
Esomeprazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.77e-05	0.000281	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000281	CcSEcCtD
Esomeprazole—Infection—Losartan—type 2 diabetes mellitus	6.72e-05	0.000279	CcSEcCtD
Esomeprazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.71e-05	0.000278	CcSEcCtD
Esomeprazole—Dyspepsia—Metformin—type 2 diabetes mellitus	6.71e-05	0.000278	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—MTR—type 2 diabetes mellitus	6.68e-05	0.00118	CbGpPWpGaD
Esomeprazole—Tremor—Ramipril—type 2 diabetes mellitus	6.66e-05	0.000276	CcSEcCtD
Esomeprazole—Shock—Losartan—type 2 diabetes mellitus	6.66e-05	0.000276	CcSEcCtD
Esomeprazole—Urticaria—Valsartan—type 2 diabetes mellitus	6.65e-05	0.000276	CcSEcCtD
Esomeprazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.64e-05	0.000275	CcSEcCtD
Esomeprazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.63e-05	0.000275	CcSEcCtD
Esomeprazole—Decreased appetite—Metformin—type 2 diabetes mellitus	6.63e-05	0.000275	CcSEcCtD
Esomeprazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.62e-05	0.000274	CcSEcCtD
Esomeprazole—Tachycardia—Losartan—type 2 diabetes mellitus	6.61e-05	0.000274	CcSEcCtD
Esomeprazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000274	CcSEcCtD
Esomeprazole—Nausea—Bromocriptine—type 2 diabetes mellitus	6.59e-05	0.000273	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.58e-05	0.000273	CcSEcCtD
Esomeprazole—Fatigue—Metformin—type 2 diabetes mellitus	6.57e-05	0.000273	CcSEcCtD
Esomeprazole—Urticaria—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000273	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000272	CcSEcCtD
Esomeprazole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.54e-05	0.000271	CcSEcCtD
Esomeprazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000271	CcSEcCtD
Esomeprazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000271	CcSEcCtD
Esomeprazole—Asthenia—Gliclazide—type 2 diabetes mellitus	6.54e-05	0.000271	CcSEcCtD
Esomeprazole—Agitation—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000271	CcSEcCtD
Esomeprazole—Constipation—Metformin—type 2 diabetes mellitus	6.52e-05	0.00027	CcSEcCtD
Esomeprazole—Angioedema—Ramipril—type 2 diabetes mellitus	6.5e-05	0.00027	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP11A1—type 2 diabetes mellitus	6.47e-05	0.00114	CbGpPWpGaD
Esomeprazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.46e-05	0.000268	CcSEcCtD
Esomeprazole—Anorexia—Losartan—type 2 diabetes mellitus	6.45e-05	0.000268	CcSEcCtD
Esomeprazole—Vomiting—Glyburide—type 2 diabetes mellitus	6.45e-05	0.000268	CcSEcCtD
Esomeprazole—Pruritus—Gliclazide—type 2 diabetes mellitus	6.44e-05	0.000267	CcSEcCtD
Esomeprazole—Malaise—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000266	CcSEcCtD
Esomeprazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.000266	CcSEcCtD
Esomeprazole—Rash—Glyburide—type 2 diabetes mellitus	6.4e-05	0.000265	CcSEcCtD
Esomeprazole—Somnolence—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000265	CcSEcCtD
Esomeprazole—Dermatitis—Glyburide—type 2 diabetes mellitus	6.39e-05	0.000265	CcSEcCtD
Esomeprazole—Vertigo—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000265	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	6.38e-05	0.00112	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	6.38e-05	0.00112	CbGpPWpGaD
Esomeprazole—Leukopenia—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000264	CcSEcCtD
Esomeprazole—Headache—Glyburide—type 2 diabetes mellitus	6.36e-05	0.000264	CcSEcCtD
Esomeprazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000263	CcSEcCtD
Esomeprazole—Palpitations—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000261	CcSEcCtD
Esomeprazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.28e-05	0.000261	CcSEcCtD
Esomeprazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000259	CcSEcCtD
Esomeprazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000259	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.23e-05	0.000259	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000258	CcSEcCtD
Esomeprazole—Cough—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000257	CcSEcCtD
Esomeprazole—Fatigue—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000257	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.17e-05	0.000256	CcSEcCtD
Esomeprazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.17e-05	0.000256	CcSEcCtD
Esomeprazole—Pain—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000255	CcSEcCtD
Esomeprazole—Constipation—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000255	CcSEcCtD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	6.13e-05	0.00108	CbGpPWpGaD
Esomeprazole—Insomnia—Losartan—type 2 diabetes mellitus	6.12e-05	0.000254	CcSEcCtD
Esomeprazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.09e-05	0.000253	CcSEcCtD
Esomeprazole—Paraesthesia—Losartan—type 2 diabetes mellitus	6.08e-05	0.000252	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	6.06e-05	0.00107	CbGpPWpGaD
Esomeprazole—Urticaria—Metformin—type 2 diabetes mellitus	6.05e-05	0.000251	CcSEcCtD
Esomeprazole—Myalgia—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000251	CcSEcCtD
Esomeprazole—Chest pain—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000251	CcSEcCtD
Esomeprazole—Arthralgia—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000251	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	6.04e-05	0.00106	CbGpPWpGaD
Esomeprazole—Dyspnoea—Losartan—type 2 diabetes mellitus	6.03e-05	0.00025	CcSEcCtD
Esomeprazole—Anxiety—Ramipril—type 2 diabetes mellitus	6.03e-05	0.00025	CcSEcCtD
Esomeprazole—Nausea—Glyburide—type 2 diabetes mellitus	6.03e-05	0.00025	CcSEcCtD
Esomeprazole—Abdominal pain—Metformin—type 2 diabetes mellitus	6.02e-05	0.00025	CcSEcCtD
Esomeprazole—Dizziness—Gliclazide—type 2 diabetes mellitus	6.02e-05	0.00025	CcSEcCtD
Esomeprazole—Somnolence—Losartan—type 2 diabetes mellitus	6.02e-05	0.00025	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000249	CcSEcCtD
Esomeprazole—Asthenia—Valsartan—type 2 diabetes mellitus	6e-05	0.000249	CcSEcCtD
Esomeprazole—Discomfort—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000248	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	5.98e-05	0.00105	CbGpPWpGaD
Esomeprazole—Dyspepsia—Losartan—type 2 diabetes mellitus	5.96e-05	0.000247	CcSEcCtD
Esomeprazole—Asthenia—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000246	CcSEcCtD
Esomeprazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000246	CcSEcCtD
Esomeprazole—Pruritus—Valsartan—type 2 diabetes mellitus	5.92e-05	0.000246	CcSEcCtD
Esomeprazole—Dry mouth—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000246	CcSEcCtD
Esomeprazole—Decreased appetite—Losartan—type 2 diabetes mellitus	5.88e-05	0.000244	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000244	CcSEcCtD
Esomeprazole—Confusional state—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000243	CcSEcCtD
Esomeprazole—Pruritus—Orlistat—type 2 diabetes mellitus	5.85e-05	0.000243	CcSEcCtD
Esomeprazole—Fatigue—Losartan—type 2 diabetes mellitus	5.84e-05	0.000242	CcSEcCtD
Esomeprazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000241	CcSEcCtD
Esomeprazole—Vomiting—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.00024	CcSEcCtD
Esomeprazole—Constipation—Losartan—type 2 diabetes mellitus	5.79e-05	0.00024	CcSEcCtD
Esomeprazole—Pain—Losartan—type 2 diabetes mellitus	5.79e-05	0.00024	CcSEcCtD
Esomeprazole—Rash—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000238	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	5.74e-05	0.00101	CbGpPWpGaD
Esomeprazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000238	CcSEcCtD
Esomeprazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000238	CcSEcCtD
Esomeprazole—Urticaria—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000237	CcSEcCtD
Esomeprazole—Shock—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000237	CcSEcCtD
Esomeprazole—Headache—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.000237	CcSEcCtD
Esomeprazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000236	CcSEcCtD
Esomeprazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000236	CcSEcCtD
Esomeprazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000236	CcSEcCtD
Esomeprazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000236	CcSEcCtD
Esomeprazole—Tachycardia—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000235	CcSEcCtD
Esomeprazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000235	CcSEcCtD
Esomeprazole—Skin disorder—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000234	CcSEcCtD
Esomeprazole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000233	CcSEcCtD
Esomeprazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.58e-05	0.000231	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.53e-05	0.00023	CcSEcCtD
Esomeprazole—Dizziness—Valsartan—type 2 diabetes mellitus	5.53e-05	0.00023	CcSEcCtD
Esomeprazole—Anorexia—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000229	CcSEcCtD
Esomeprazole—Dizziness—Orlistat—type 2 diabetes mellitus	5.47e-05	0.000227	CcSEcCtD
Esomeprazole—Asthenia—Metformin—type 2 diabetes mellitus	5.47e-05	0.000227	CcSEcCtD
Esomeprazole—Nausea—Gliclazide—type 2 diabetes mellitus	5.41e-05	0.000224	CcSEcCtD
Esomeprazole—Pruritus—Metformin—type 2 diabetes mellitus	5.39e-05	0.000224	CcSEcCtD
Esomeprazole—Urticaria—Losartan—type 2 diabetes mellitus	5.38e-05	0.000223	CcSEcCtD
Esomeprazole—Abdominal pain—Losartan—type 2 diabetes mellitus	5.35e-05	0.000222	CcSEcCtD
Esomeprazole—Body temperature increased—Losartan—type 2 diabetes mellitus	5.35e-05	0.000222	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP2E1—type 2 diabetes mellitus	5.34e-05	0.00094	CbGpPWpGaD
Esomeprazole—Vomiting—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000221	CcSEcCtD
Esomeprazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.00022	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000219	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP1A2—type 2 diabetes mellitus	5.28e-05	0.000929	CbGpPWpGaD
Esomeprazole—Rash—Valsartan—type 2 diabetes mellitus	5.28e-05	0.000219	CcSEcCtD
Esomeprazole—Dermatitis—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000219	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	5.27e-05	0.000927	CbGpPWpGaD
Esomeprazole—Vomiting—Orlistat—type 2 diabetes mellitus	5.26e-05	0.000218	CcSEcCtD
Esomeprazole—Insomnia—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000218	CcSEcCtD
Esomeprazole—Headache—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000217	CcSEcCtD
Esomeprazole—Diarrhoea—Metformin—type 2 diabetes mellitus	5.21e-05	0.000216	CcSEcCtD
Esomeprazole—Rash—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000216	CcSEcCtD
Esomeprazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000216	CcSEcCtD
Esomeprazole—Dermatitis—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000216	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	5.21e-05	0.000916	CbGpPWpGaD
Esomeprazole—Headache—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000215	CcSEcCtD
Esomeprazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000215	CcSEcCtD
Esomeprazole—Asthenia—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000214	CcSEcCtD
Esomeprazole—Somnolence—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000214	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP3A4—type 2 diabetes mellitus	5.15e-05	0.000906	CbGpPWpGaD
Esomeprazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000212	CcSEcCtD
Esomeprazole—Pruritus—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000211	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	5.08e-05	0.000894	CbGpPWpGaD
Esomeprazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000209	CcSEcCtD
Esomeprazole—Dizziness—Metformin—type 2 diabetes mellitus	5.04e-05	0.000209	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000208	CcSEcCtD
Esomeprazole—Fatigue—Ramipril—type 2 diabetes mellitus	5e-05	0.000208	CcSEcCtD
Esomeprazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.99e-05	0.000207	CcSEcCtD
Esomeprazole—Nausea—Valsartan—type 2 diabetes mellitus	4.97e-05	0.000206	CcSEcCtD
Esomeprazole—Constipation—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000206	CcSEcCtD
Esomeprazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000204	CcSEcCtD
Esomeprazole—Nausea—Orlistat—type 2 diabetes mellitus	4.91e-05	0.000204	CcSEcCtD
Esomeprazole—Asthenia—Losartan—type 2 diabetes mellitus	4.86e-05	0.000201	CcSEcCtD
Esomeprazole—Vomiting—Metformin—type 2 diabetes mellitus	4.85e-05	0.000201	CcSEcCtD
Esomeprazole—Rash—Metformin—type 2 diabetes mellitus	4.81e-05	0.000199	CcSEcCtD
Esomeprazole—Dermatitis—Metformin—type 2 diabetes mellitus	4.8e-05	0.000199	CcSEcCtD
Esomeprazole—Pruritus—Losartan—type 2 diabetes mellitus	4.79e-05	0.000199	CcSEcCtD
Esomeprazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000198	CcSEcCtD
Esomeprazole—Headache—Metformin—type 2 diabetes mellitus	4.77e-05	0.000198	CcSEcCtD
Esomeprazole—Dizziness—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000197	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000197	CcSEcCtD
Esomeprazole—Diarrhoea—Losartan—type 2 diabetes mellitus	4.63e-05	0.000192	CcSEcCtD
Esomeprazole—Urticaria—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000191	CcSEcCtD
Esomeprazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.59e-05	0.00019	CcSEcCtD
Esomeprazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.59e-05	0.00019	CcSEcCtD
Esomeprazole—Vomiting—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.00019	CcSEcCtD
Esomeprazole—Rash—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000188	CcSEcCtD
Esomeprazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000188	CcSEcCtD
Esomeprazole—Nausea—Metformin—type 2 diabetes mellitus	4.53e-05	0.000188	CcSEcCtD
Esomeprazole—Headache—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000187	CcSEcCtD
Esomeprazole—Dizziness—Losartan—type 2 diabetes mellitus	4.48e-05	0.000186	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	4.47e-05	0.000786	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	4.35e-05	0.000766	CbGpPWpGaD
Esomeprazole—Vomiting—Losartan—type 2 diabetes mellitus	4.3e-05	0.000179	CcSEcCtD
Esomeprazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000177	CcSEcCtD
Esomeprazole—Nausea—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000177	CcSEcCtD
Esomeprazole—Rash—Losartan—type 2 diabetes mellitus	4.27e-05	0.000177	CcSEcCtD
Esomeprazole—Dermatitis—Losartan—type 2 diabetes mellitus	4.26e-05	0.000177	CcSEcCtD
Esomeprazole—Headache—Losartan—type 2 diabetes mellitus	4.24e-05	0.000176	CcSEcCtD
Esomeprazole—Asthenia—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000173	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	4.15e-05	0.00073	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	4.15e-05	0.00073	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	4.15e-05	0.00073	CbGpPWpGaD
Esomeprazole—Pruritus—Ramipril—type 2 diabetes mellitus	4.11e-05	0.00017	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.05e-05	0.000712	CbGpPWpGaD
Esomeprazole—Nausea—Losartan—type 2 diabetes mellitus	4.02e-05	0.000167	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.02e-05	0.000707	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.99e-05	0.000702	CbGpPWpGaD
Esomeprazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000165	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.89e-05	0.000684	CbGpPWpGaD
Esomeprazole—Dizziness—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000159	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.84e-05	0.000675	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	3.76e-05	0.000662	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	3.7e-05	0.000651	CbGpPWpGaD
Esomeprazole—Vomiting—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000153	CcSEcCtD
Esomeprazole—Rash—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000152	CcSEcCtD
Esomeprazole—Dermatitis—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000152	CcSEcCtD
Esomeprazole—Headache—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000151	CcSEcCtD
Esomeprazole—Nausea—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000143	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.21e-05	0.000565	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.18e-05	0.000559	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.17e-05	0.000557	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.15e-05	0.000554	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.15e-05	0.000554	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.13e-05	0.000551	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BHMT—type 2 diabetes mellitus	3.09e-05	0.000543	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGDS—type 2 diabetes mellitus	2.7e-05	0.000475	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AANAT—type 2 diabetes mellitus	2.7e-05	0.000475	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.56e-05	0.000451	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CDO1—type 2 diabetes mellitus	2.56e-05	0.00045	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPD2—type 2 diabetes mellitus	2.56e-05	0.00045	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.5e-05	0.00044	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.48e-05	0.000437	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	2.44e-05	0.000429	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.43e-05	0.000428	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.41e-05	0.000424	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.4e-05	0.000422	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	2.25e-05	0.000396	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	2.25e-05	0.000396	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.24e-05	0.000394	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.2e-05	0.000387	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.18e-05	0.000384	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	2.17e-05	0.000383	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.17e-05	0.000383	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	2.17e-05	0.000383	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	2.17e-05	0.000383	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	2.17e-05	0.000383	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	2.11e-05	0.000371	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.03e-05	0.000357	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	1.99e-05	0.00035	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	1.99e-05	0.00035	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	1.94e-05	0.000341	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.86e-05	0.000327	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	1.85e-05	0.000325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	1.85e-05	0.000325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	1.85e-05	0.000325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	1.77e-05	0.000312	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	1.77e-05	0.000312	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.71e-05	0.0003	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.71e-05	0.0003	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.68e-05	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.68e-05	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.65e-05	0.00029	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.65e-05	0.00029	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.65e-05	0.00029	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.62e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.62e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.6e-05	0.000281	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.55e-05	0.000273	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.54e-05	0.000271	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.54e-05	0.000271	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.53e-05	0.000268	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.49e-05	0.000262	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.47e-05	0.000258	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.45e-05	0.000255	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.45e-05	0.000255	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.4e-05	0.000247	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.4e-05	0.000247	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.4e-05	0.000247	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.4e-05	0.000247	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.35e-05	0.000238	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.35e-05	0.000238	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.35e-05	0.000237	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.34e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.31e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.31e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.31e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.31e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.31e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.3e-05	0.00023	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.28e-05	0.000225	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.27e-05	0.000223	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.26e-05	0.000222	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.25e-05	0.00022	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.2e-05	0.00021	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.2e-05	0.00021	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	1.17e-05	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.17e-05	0.000205	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	1.14e-05	0.000201	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	1.14e-05	0.000201	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	1.12e-05	0.000197	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	1.11e-05	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.09e-05	0.000191	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.07e-05	0.000189	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.07e-05	0.000188	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.07e-05	0.000188	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.01e-05	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1e-05	0.000176	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	9.98e-06	0.000176	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	9.98e-06	0.000176	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	9.98e-06	0.000176	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.91e-06	0.000174	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.91e-06	0.000174	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.91e-06	0.000174	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	9.8e-06	0.000172	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	9.71e-06	0.000171	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.58e-06	0.000169	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	9.5e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.32e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	9.13e-06	0.000161	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	9.03e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	9.03e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	8.81e-06	0.000155	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.76e-06	0.000154	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.72e-06	0.000154	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	8.66e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	8.66e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.08e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.51e-06	0.000132	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	7.46e-06	0.000131	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.46e-06	0.000131	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	7.43e-06	0.000131	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	7.33e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	7.11e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.01e-06	0.000123	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	6.92e-06	0.000122	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.87e-06	0.000121	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.87e-06	0.000121	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	6.79e-06	0.00012	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.74e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.69e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.69e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.69e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.65e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	6.65e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	6.63e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.46e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	6.45e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	6.37e-06	0.000112	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	6.12e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	6e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.89e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.84e-06	0.000103	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	5.81e-06	0.000102	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.72e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	5.71e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	5.69e-06	0.0001	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	5.63e-06	9.9e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.49e-06	9.66e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.43e-06	9.55e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.43e-06	9.55e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.21e-06	9.16e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.21e-06	9.16e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.96e-06	8.73e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.86e-06	8.56e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.49e-06	7.89e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.49e-06	7.89e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.47e-06	7.86e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.46e-06	7.85e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.41e-06	7.75e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.28e-06	7.53e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.27e-06	7.51e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.27e-06	7.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.16e-06	7.32e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.08e-06	7.19e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4e-06	7.04e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.99e-06	7.01e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.9e-06	6.86e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.88e-06	6.83e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.83e-06	6.74e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.68e-06	6.47e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.61e-06	6.35e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.49e-06	6.15e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.44e-06	6.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.42e-06	6.02e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.38e-06	5.96e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.98e-06	5.25e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.93e-06	5.15e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.68e-06	4.72e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-06	4.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-06	4.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-06	4.13e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.96e-06	3.45e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	2.07e-05	CbGpPWpGaD
